0.9193

1.16% -0.0108

60 Degrees Pharmaceuticals Inc (SXTP)

Overview News Price History Why SXTP Down? Discussions Forecast

60 Degrees Pharmaceuticals Inc stock is traded at $0.9193, with a volume of 57,814. It is down -1.16% in the last 24 hours and down -25.26% over the past month. 60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.

Previous Close:

$0.9301

Open:

$0.9298

24h Volume:

57,814

Relative Volume:

0.59

Market Cap:

$3.23M

Revenue:

$1.31M

Net Income/Loss:

$-7.56M

P/E Ratio:

-0.0893

EPS:

-10.2926

Net Cash Flow:

$-8.25M

1W Performance:

-10.75%

1M Performance:

-25.26%

6M Performance:

-59.50%

1Y Performance:

-84.47%

1-Day Range:

$0.8967

$0.9888

1-Week Range:

$0.8967

$1.09

52-Week Range:

$0.8967

$8.62

60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile

Name

60 Degrees Pharmaceuticals Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

202-327-5422

Address

1025 CONNECTICUT AVENUE NW, WASHINGTON

Employee

Twitter

Next Earnings Date

2026-08-12

Latest SEC Filings

SXTP's Discussions on Twitter

Compare SXTP vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SXTP 60 Degrees Pharmaceuticals Inc	0.9193	3.97M	1.31M	-7.56M	-8.25M	-10.29
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News

Aug 20, 2026

Degrees (SXTP) Quarter in Focus: The Bottom-Line Figure Trails Its Comparison under the Current Snapshot; The Stock Finishes Near Unchanged in the Latest ReadingShare Dilution Risk - vinanet.vn

Aug 20, 2026

Aug 17, 2026

H.C. Wainwright Maintains 60 Degrees Pharmaceuticals(SXTP.US) With Hold Rating - Moomoo

Aug 17, 2026

SXTP Q1 2026 Earnings: Widened Loss of -$1.28 Per Share Misses Estimates as Stock Declines 5.77%Margin Improvement Report - vinanet.vn

Aug 17, 2026

Aug 16, 2026

60 Degrees Pharmaceuticals (SXTP) Edges Higher, Holding Above $1.14 SupportOption Breadth - Vinanet

Aug 16, 2026

SXTP Q1 2026 Earnings: EPS Miss of 65.12% Exposes Pre-Revenue Pipeline Cost PressuresGross Profit Margin - vinanet.vn

Aug 16, 2026

Aug 14, 2026

60 Degrees Pharmaceuticals (NASDAQ: SXTP) files to register 1.77M resale shares from warrant deal - Stock Titan

Aug 14, 2026

60 Degrees Q2 revenue jumps 106% to $208K; loss widens - scanx.trade

Aug 14, 2026

ARAKODA maker reports about $2.4M Q2 loss with about $208K revenue - Stock Titan

Aug 14, 2026

60 Degrees Pharmaceuticals (SXTP) flags going concern risk as losses deepen - Stock Titan

Aug 14, 2026

60 Degrees Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 14, 2026

Aug 10, 2026

60 Degrees Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:SXTPW - TradingView

Aug 10, 2026

Aug 07, 2026